Including Column Separation Means Patents (Class 435/288.6)
-
Patent number: 8187866Abstract: An optical scanning system including a switchable light source, a detector, a substrate and a plurality of optical sensing sites, as well s methods and kits for use thereof are provided. The substrate is coupled to and in optical communication with the switchable light source and the detector. Additionally, the substrate includes a plurality of substantially parallel excitation waveguides, and a plurality of substantially parallel collection waveguides, the excitation waveguides and collection waveguides crossing to form a two-dimensional array of intersection regions where an excitation waveguide and a collection waveguide cross and provide optical communication with the intersection region at each crossing. The plurality of optical sensing sites are each in optical communication with an intersection region.Type: GrantFiled: May 17, 2011Date of Patent: May 29, 2012Assignee: PLC Diagnostics, Inc.Inventor: Reuven Duer
-
Patent number: 8158349Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: GrantFiled: January 14, 2011Date of Patent: April 17, 2012Assignee: Roche Molecular Systems, Inc.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Patent number: 8153417Abstract: Apparatus and method for handling biological samples. Segments of ionic liquid can provide voltage across segments of immiscible liquid to concentrate or separate charged species in the biological samples. Reactants in biological samples can be contacted and reacted in segments of immiscible liquid.Type: GrantFiled: November 17, 2010Date of Patent: April 10, 2012Assignee: Applied Biosystems, LLC.Inventors: Zbigniew T. Bryning, Timothy Z. Liu
-
Publication number: 20120058549Abstract: A method of analyzing vitamin E components in a lipoproteinby subjecting a lipoprotein-containing sample to ion exchange chromatography to separate the lipoprotein, reacting the separated lipoprotein to a pretreating solution containing an organic solvent and a surfactant to liberate vitamin E components, and then subjecting the liberated vitamin E components to reverse phase chromatography. Also described is a method of judging various pathological conditions such as the pathological conditions of diabetes, the risks of coronary artery diseases, and the pathological conditions of myocardial infarction using levels of vitamin E components in the lipoprotein as an index.Type: ApplicationFiled: November 4, 2011Publication date: March 8, 2012Applicant: TOSOH CORPORATIONInventor: Yuji HIROWATARI
-
Patent number: 8110403Abstract: It is an object of the present invention to provide an immunoassay method which is capable of simultaneous quantification of a plurality of test substances under a same analysis condition, through adjustment of the measurement sensitivity/range by simply varying the size of particles for use as labels, without changing the spectra of these particles.Type: GrantFiled: February 11, 2009Date of Patent: February 7, 2012Assignee: Fujifilm CorporationInventors: Tadahiro Matsuno, Kentaro Nakamura
-
Patent number: 8017353Abstract: A chemostat is described that includes a growth chamber having a plurality of compartments. Each of the compartments may be fluidly isolated from the rest of the growth chamber by one or more actuatable valves. The chemostat may also include a nutrient supply-line to supply growth medium to the growth chamber, and an output port to remove fluids from the growth chamber. Also, a method of preventing biofilm formation in a growth chamber of a chemostat is described. The method may include the steps of adding a lysis agent to a isolated portion of the growth chamber, and reuniting the isolated portion with the rest of the growth chamber.Type: GrantFiled: July 29, 2008Date of Patent: September 13, 2011Assignee: California Institute of TechnologyInventors: Frederick Balagadde, Carl L. Hansen, Emil Kartalov, Stephen R. Quake
-
Patent number: 8003376Abstract: The invention provides methods and devices for detecting the presence of one or more target analytes in a sample employing a channel having affixed therein one or more binding partners for each target analyte. Assays are carried out by transporting the sample through the channel to each successive binding partner so that target analyte present in said sample binds to the corresponding binding partner. The sample is then transported beyond the binding partner(s), followed by detection of any target analyte bound to each binding partner. In one embodiment, binding efficiency is increased by the use of segmented transport, wherein a first bolus or bubble of a fluid that is immiscible with the sample precedes the sample during transport and a second bolus or bubble of a fluid that is immiscible with the sample follows the sample. Many configurations are possible for the device of the invention.Type: GrantFiled: May 5, 2010Date of Patent: August 23, 2011Assignee: The Regents of the University of CaliforniaInventors: Mack J. Fulwyler, Joe W. Gray
-
Patent number: 7998696Abstract: A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber.Type: GrantFiled: December 5, 2008Date of Patent: August 16, 2011Assignee: Zyomyx, Inc.Inventors: Frank Zaugg, Renee Tobias, Silvia McManus-Munoz, Peter Kernen, Laurence Ruiz-Taylor, Peter Wagner
-
Patent number: 7993507Abstract: The present invention is related to a method of separation of compounds by electrophoresis in which the compounds such as genes, proteins, etc. may be analyzed very precisely as samples are introduced directly into the separation tubes of the chip at the collection site, and therefore, it is not necessary to have separate fluid paths or individual sample storing apparatus that have been necessary for the conventional electrophoresis; it is easy to make the chips as the structure of the chip becomes extremely simple, and high-density arrangement of the separation tubes is enabled; and further, the compounds such as genes, proteins, etc. may be analyzed very precisely without interference in the storage tubs by using a non-polar solvent as the solvent of the sample storage tub.Type: GrantFiled: November 16, 2005Date of Patent: August 9, 2011Assignee: Korea Research Institute of Standards and ScienceInventors: Sang-Ryoul Park, In-Chul Yang, Young-Ho Kim
-
Publication number: 20110159523Abstract: Described herein is a method that may be used in various applications, such as drug development, medical diognosis and gene/protein therapy. In one embodiment, the subject matter discloses an effective method for identification and quantification of large sets of proteins/peptides in vitro and cells in vivo.Type: ApplicationFiled: June 27, 2008Publication date: June 30, 2011Applicant: CEDARS-SINAI MEDICAL CENTERInventors: Parag Mallick, Jeremy C. Collette
-
Patent number: 7959861Abstract: Device and method for detecting the presence of known or unknown toxic agents in a fluid sample. Targets in the sample are bound to releasable receptors immobilized in a reaction region of a micro- or nano-fluidic device. The receptors are selected based on their affinity for classes of known toxic agents. The receptors are freed and the bound and unbound receptors separated based on differential electrokinetic mobilities while they travel to a detection device.Type: GrantFiled: April 14, 2008Date of Patent: June 14, 2011Assignee: STC.UNMInventors: Gabriel Lopez, Linnea Ista, Steven R J Brueck, Aurelio Evangelista Lara, Mangesh Bore
-
Patent number: 7955867Abstract: In the present invention cells are placed in a multiwell plate and grown. When the assay is to be performed, one uses gravity to wash away any unbound ligands rather than vacuum or centrifugation. The cells are then examined to detect the bound ligand. To perform the washing step(s) the plate is placed into a carrier plate having open wells in register with the wells of the filter plate or one may use a wicking device or an underdrain attached to the bottom of the filter plate. Sufficient wash liquid is added to allow for filtration by the effect of gravity to occur. Cells are retained within the wells at a rate of 4 times that of other rapid methods.Type: GrantFiled: January 18, 2008Date of Patent: June 7, 2011Assignee: Millipore CorporationInventor: Jun Y. Park
-
Patent number: 7943397Abstract: The enumeration of cells in fluids by flow cytometry is widely used across many disciplines such as assessment of leukocyte subsets in different bodily fluids or of bacterial contamination in environmental samples, food products and bodily fluids. For many applications the cost, size and complexity of the instruments prevents wider use, for example, CD4 analysis in HIV monitoring in resource-poor countries. The novel device, methods and algorithms disclosed herein largely overcome these limitations. Briefly, all cells in a biological sample are fluorescently labeled, but only the target cells are also magnetically labeled. The labeled sample, in a chamber or cuvet, is placed between two wedge-shaped magnets to selectively move the magnetically labeled cells to the observation surface of the cuvet. An LED illuminates the cells and a CCD camera captures the images of the fluorescent light emitted by the target cells.Type: GrantFiled: July 30, 2004Date of Patent: May 17, 2011Assignee: Veridex, LLCInventors: Arjan Tibbe, Jan Greve, Dhanesh Gohel, Erik Droog, Leon W. M. M. Terstappen
-
Patent number: 7943368Abstract: Methods for reducing time to result in blood bank diagnostic testing with an agitation device and a low ionic strength solution are disclosed. Specifically provided are methods for reducing incubation time for antigen-antibody reactions in an immunohematologic assay by subjecting the assay reactants to incubation with agitation and optionally additionally a low ionic strength diluent.Type: GrantFiled: May 4, 2010Date of Patent: May 17, 2011Assignee: Micro Typing Systems, Inc.Inventors: Harry Malyska, Paula Howard
-
Publication number: 20110111451Abstract: A device for evaluating the blood content in a plurality of media may include a display having a plurality of columns, each column having a plurality of color-block rows, where the colors are created by diluting blood in the respective medium to obtain a color, and then substantially matching that color with a row in the column. Additionally or alternatively, the columns may represent blood diluted in the same sample, but observed at different times. The display may include gaps between columns to accept a catheter in which the sample to be analyzed is placed and a legend identifying the medium and blood dilution for each column and row, as well as the time of aging, if any, for a column.Type: ApplicationFiled: November 12, 2009Publication date: May 12, 2011Inventor: Steven Y. Chung
-
Patent number: 7932082Abstract: A device is disclosed for extracting a smear sample. The device includes a cavity, into which a sample carrier carrying a smear sample can be introduced. Liquid can be introduced into the cavity through at least one liquid feed connected to the cavity, and the liquid can be removed from the cavity through at least one liquid discharge connected to the cavity.Type: GrantFiled: November 15, 2006Date of Patent: April 26, 2011Assignee: Siemens AktiengesellschaftInventors: Klaus Abraham-Fuchs, Thomas Ehben, Walter Gumbrecht, Peter Paulicka, Sebastian Schmidt, Manfred Stanzel, Christian Zilch
-
Patent number: 7897378Abstract: The invention concerns a method for isolating and purifying nucleic acids from a sample and a device that is suitable therefore.Type: GrantFiled: February 7, 2005Date of Patent: March 1, 2011Assignee: Roche Molecular Systems, Inc.Inventors: Dirk Block, Ruediger Haenel, Joerg Kleiber, Manuela Poignee-Heger, Thomas Walter, Ralf Zielenski
-
Patent number: 7892819Abstract: Disclosed are devices for amplifying a preselected polynucleotide in a sample by conducting a polynucleotide amplification reaction. The devices are provided with a substrate microfabricated to include a polynucleotide amplification reaction, chamber, having at least one cross-sectional dimension of about 0.1 to 1000 ?m. The device also includes at least one port in fluid communication with the reaction chamber, for introducing a sample to the chamber, for venting the chamber when necessary, and, optionally, for removing products or waste material from the device. The reaction chamber may be provided with reagents required for amplification of a preselected polynucleotide. The device also may include means for thermally regulating the contents of the reaction chamber, to amplify a preselected polynucleotide. Preferably, the reaction chamber is fabricated with a high surface to volume ratio, to facilitate thermal regulation.Type: GrantFiled: August 11, 2003Date of Patent: February 22, 2011Assignee: Trustees of the University of PennsylvaniaInventors: Peter Wilding, Larry J. Kricka
-
Publication number: 20100311085Abstract: A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber.Type: ApplicationFiled: August 20, 2010Publication date: December 9, 2010Inventors: Frank Zaugg, Renee Tobias, Silvia McManus-Munoz, Peter Kernen, Laurence Ruiz-Taylor, Peter Wagner
-
Patent number: 7799553Abstract: Methods and apparatus for genome analysis are provided. A microfabricated structure including a microfluidic distribution channel is configured to distribute microreactor elements having copies of a sequencing template into a plurality of microfabricated thermal cycling chambers. A microreactor element may include a microcarrier element carrying the multiple copies of the sequencing template. The microcarrier element may comprise a microsphere. An autovalve at an exit port of a thermal cycling chamber, an optical scanner, or a timing arrangement may be used to ensure that only one microsphere will flow into one thermal cycling chamber wherein thermal cycling extension fragments are produced. The extension products are captured, purified, and concentrated in an integrated oligonucleotide gel capture chamber. A microfabricated component separation apparatus is used to analyze the purified extension fragments.Type: GrantFiled: May 25, 2005Date of Patent: September 21, 2010Assignee: The Regents of the University of CaliforniaInventors: Richard A. Mathies, Robert Blazej, Chung Liu, Palani Kumaresan, Stephanie H. I. Yeung
-
Patent number: 7790475Abstract: The present invention is directed to apparatuses and methods for reducing the content of albumin in serum, plasma and/or blood samples. The apparatuses comprise an insoluble support with a ligand attached thereto. According to certain embodiments of the invention, the ligand is a bromosulfophthalein, Cibacron Blue or Warfarin ligand or salts or esters thereof. Also provided are methods of making the apparatus, as well as kits and albumin-depleted samples produced by the methods of the present invention.Type: GrantFiled: August 19, 2004Date of Patent: September 7, 2010Assignee: Becton, Dickinson and CompanyInventor: William Galbraith
-
Patent number: 7767436Abstract: Methods for reducing time to result in blood bank diagnostic testing with an agitation device and a low ionic strength solution are disclosed. Specifically provided are methods for reducing incubation time for antigen-antibody reactions in an immunohematologic assay by subjecting the assay reactants to incubation with agitation and optionally additionally a low ionic strength diluent.Type: GrantFiled: December 17, 2004Date of Patent: August 3, 2010Assignee: Micro Typing Systems, Inc.Inventors: Harry Malyska, Paula Howard
-
Patent number: 7765698Abstract: A method of making an electret article, from a polymeric article that has a zeta potential of greater than or less than ?7.5 millivolts. The article is charged by contacting it with an aqueous liquid that has a pH and conductivity as follows: (i) if the article has a zeta potential of ?7.5 mV or less, then the contacting liquid has pH greater than 7 and a conductivity of 5 to 9,000 microSiemens per centimeter; and (ii) if the article has a zeta potential of greater than ?7.5 mV, then the contacting liquid has a pH of 7 or less and a conductivity of 5 to 5,500 microSiemens per centimeter. An electret article made in this manner can provide improved electret performance, particularly in electret filtration articles.Type: GrantFiled: June 2, 2008Date of Patent: August 3, 2010Assignee: 3M Innovative Properties CompanyInventors: John M. Sebastian, Marvin E. Jones, Fuming B. Li, Shih-Hung Chou, Nathan E. Schultz, Justin L. Keough, Rahul R. Shah, Daniel A. Japuntich
-
Publication number: 20100190146Abstract: Microfluidic devices and methods for analyzing glycan profiles of glycoproteins are provided. Some embodiments of the devices comprise a deglycosylation column for cleaving glycans, an optional cleaning column for removing proteins, a trapping column for enriching glycans, and a separation column for resolving glycans. The devices and methods significantly improve the speed and sensitivity of glycan analysis.Type: ApplicationFiled: January 29, 2009Publication date: July 29, 2010Inventors: Magdalena A. Bynum, Rudolf Grimm, Kevin P. Killeen, Karia M. Robotti
-
Patent number: 7759112Abstract: Methods and devices for isolating nucleic acids from a mixture containing such nucleic acids and extraneous matter are provided. In one embodiment, the method of the invention comprises passing the mixture through a glass frit under conditions effective to separate the nucleic acids from the extraneous matter. In a more specific embodiment, the glass frit is a sintered glass frit.Type: GrantFiled: October 31, 2007Date of Patent: July 20, 2010Assignee: Akonni Biosystems, Inc.Inventor: Philip Belgrader
-
Publication number: 20100178663Abstract: Embodiments of the present invention feature the determination of normetanephrine, metanephrine and 3-methoxytyraminein raw human plasma with minimal sample pretreatment using a weak cationic extraction media to provide a selective sample clean-up and HILIC chemistries as indicators of pheochromoacytoma.Type: ApplicationFiled: May 13, 2008Publication date: July 15, 2010Applicant: WATERS TECHNOLOGIES CORPORATIONInventors: Kendon Stuart Graham, Ido P. Kema, Donald P. Cooper
-
Publication number: 20100151440Abstract: Provided herein are high throughput methods for converting starch-containing plant material to ethanol, wherein the conversion process is performed at a small scale. This high-throughput screening platform permits the evaluation of the ethanol obtained from starch-containing plant material in a rapid and efficient manner. The methods include obtaining a plurality of samples of starch-containing plant material and drying the samples to achieve a desired moisture level. The dried samples are liquefied under conditions sufficient to hydrolyze the starch-containing plant material to soluble dextrinized substrates. The liquefied samples are fermented in small volume headspace vials for a period of less than about 96 hours, and fermentation is terminated by pasteurization. Ethanol production is evaluated using headspace gas chromatography.Type: ApplicationFiled: November 25, 2009Publication date: June 17, 2010Applicant: Syngenta Participations AG,Inventors: Jason Abbas, George Aux, Joe Byrum, My Nguyen, Kirk Noel, Mark P. Seymour
-
Patent number: 7727473Abstract: A cassette for preparing a sample is disclosed herein. The cassette includes a housing, which encloses the structures and the processes used to prepare the sample.Type: GrantFiled: October 17, 2006Date of Patent: June 1, 2010Assignee: Progentech LimitedInventors: Jesus Ching, David Hsiang Hu, Steve Jia Chang Yu, Phillip You Fai Lee
-
Publication number: 20100116658Abstract: An analyser and method for determining the relative importance of fractions of biological mixtures projects data obtained from at least two mixtures with different physiological conditions by chromatographic or mass spectrometric measurement into a second attribute space using a projection technique such as principal component analysis. The projected data is then filtered using a feature selection method such as ReliefF, before being projected back to the first attribute space using a reversion of the projection technique. This back-projected data is then filtered using another feature selection method such as ReliefF before being output in a human-readable form.Type: ApplicationFiled: May 28, 2008Publication date: May 13, 2010Inventors: Tomislav Smuc, Fran Supek
-
Patent number: 7709212Abstract: The present invention provides a method for detecting the presence or amount of an analyte in a sample, said method comprising: a porous surface to which particles having attached thereto a binding substance, analyte and binding substance coated label particles are added. If said analyte is present in the sample an immuno- or chemical reaction occurs in the liquid phase. The separation of bound complex from unbound material is achieved by using said surface where the separation occurs mainly two dimensionally on the surface of the porous surface (e.g. grid). Interestingly, the disclosed surface enables a separation where said complexes are distributed two dimensionally on the porous surface (e.g. grid), whereas unbound materials are distributed three dimensionally. Accordingly, said surface enables both a two and a three dimensional separation.Type: GrantFiled: November 23, 2005Date of Patent: May 4, 2010Assignee: Orion Diagnostica OyInventors: Juhani Luotola, Hannu Nikula, Mira Murtovuori
-
Patent number: 7662643Abstract: A membrane-based assay device for detecting the presence or quantity of an analyte residing in a test sample is provided. The device utilizes a chromatographic zone on which is disposed a plurality of microporous particles. The chromatographic zone can effectively reduce the “hook effect” in a simple, efficient, and relatively inexpensive manner. In particular, the plurality of microporous particles allows larger-sized analyte/probe complexes to reach the detection zone before the uncomplexed analyte. Because the uncomplexed analyte is substantially inhibited from competing with the complexes for the binding sites at the detection zone, the incidence of “false negatives” may be limited, even at relatively high analyte concentrations.Type: GrantFiled: July 20, 2007Date of Patent: February 16, 2010Assignee: Kimberly-Clark Worldwide, Inc.Inventors: Ning Wei, Yanbin Huang
-
Patent number: 7662637Abstract: Methods and apparatus (FIG. 4a) are disclosed for selective and very sensitive detection of certain hydrolyzable compounds, especially urea, in water by hydrolyzing said hydrolyzable compounds in a sample of the water to one or more carbon dioxide group compounds and determining the difference in the carbon dioxide content of the water and the hydrolyzed sample using conductivity measurements or other carbon dioxide detector outputs.Type: GrantFiled: December 2, 2002Date of Patent: February 16, 2010Assignee: GE Analytical InstrumentsInventor: Richard D. Godec
-
Patent number: 7642089Abstract: Removal of abundant proteins from a sample enhances detection and resolution of less abundant proteins in the sample such as in two-dimensional gel electrophoresis. The removal is accomplished by immunosubtraction of several high abundance, interfering or contaminating proteins simultaneously.Type: GrantFiled: January 9, 2002Date of Patent: January 5, 2010Assignee: Agilent Technologies, Inc.Inventors: Rembert Pieper, N. Leigh Anderson
-
Publication number: 20090286226Abstract: A simple membrane assay method for detecting or quantitating an analyte in a specimen sample using an assay device equipped with a membrane bound with a capture-substance to capture the analyte, including the steps of filtering a specimen sample using a filter, dropping the filtrate onto said membrane and detecting the presence of the analyte in said specimen sample, as well as a simple membrane assay kit for detecting the presence of an analyte in a specimen sample, including (1) a filter tube, and (2) an assay device equipped with a membrane bound with a capture-substance to capture the analyte. The method or the kit can decrease the occurrence of false positivity and can provide a highly accurate detection of the analyte such as pathogen and antibody in a specimen collected in a medical scene or by an individual.Type: ApplicationFiled: July 20, 2009Publication date: November 19, 2009Applicant: DENKA SEIKEN Co., Ltd.Inventors: Hideharu Shimizu, Takeshi Watanabe, Kazuyuki Takizawa, Junji Matsuda, Toshinori Sato
-
Publication number: 20090275119Abstract: The present invention relates to a liquid chromatography apparatus X, which is provided with a deaerator 4. The liquid chromatography apparatus X is further provided with a dissolved oxygen density adjusting means for maintaining a density of dissolved oxygen in an eluting solution to be supplied to a column 60 constant. Preferably, the dissolved oxygen density adjusting means is configured so as to adjust the density of the dissolved oxygen in the eluting solution by adjusting a degree of decompression in a decompression space of the deaerator 4 based on a measurement result by temperature measurement means 40A, 40B, and 40C for measuring the temperature of the eluting solution.Type: ApplicationFiled: February 8, 2007Publication date: November 5, 2009Applicant: ARKRAY, INC.Inventors: Koji Sugiyama, Toshikatsu Sakai, Yoshikiyo Hongo, Akira Sezaki, Takanori Kamada
-
Publication number: 20090215157Abstract: The present disclosure relates to methods, systems, devices, and microfluidic chips that may be used for the detection of pathogens.Type: ApplicationFiled: September 28, 2007Publication date: August 27, 2009Inventors: Edward K.Y. Jung, Eric C. Leuthardt, Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D. Rinaldo, JR., Lowell L. Wood, JR.
-
Publication number: 20090208981Abstract: A method and an apparatus are provided for analyzing the interaction between small molecules and cells without using density gradient and antibody but using a column packed with identical resin particles. The interactions between cell surface and resin particles resulting in the different retention time of cells treating by different small molecules in the column contributed to examining whether the small molecule could interact with cell or not. This invention can also apply small molecule screening, drug screening through examining the retention time by using the column.Type: ApplicationFiled: March 29, 2009Publication date: August 20, 2009Inventor: Jia-Ming CHANG
-
Publication number: 20090203068Abstract: A method and system for obtaining samples for proteomic analysis that utilizes pressure and a preselected agent to obtain a processing sample in a significantly shorter period of time than prior art methods and which maintains the integrity of the processing sample through the preparatory process. In one embodiment of the invention, a sample and an enzyme are combined and subjected to a pressure, preferably a pressure cycle range that varies between 0 to 35 kpsi, for a period of time of preferably less than 60 seconds. This process results in producing a sample suitable for analysis, which is preferably introduced to another analytical instrument such as a mass spectrometry instrument, or other device.Type: ApplicationFiled: July 31, 2008Publication date: August 13, 2009Inventor: Daniel Lopez-Ferrer
-
Patent number: 7572409Abstract: Apparatus and method for handling biological samples. Segments of ionic liquid can provide voltage across segments of immiscible liquid to concentrate or separate charged species in the biological samples. Reactants in biological samples can be contacted and reacted in segments of immiscible liquid.Type: GrantFiled: May 23, 2003Date of Patent: August 11, 2009Assignee: Applied Biosystems, LLCInventors: Zbigniew T. Bryning, Timothy Z. Liu
-
Publication number: 20090061507Abstract: The invention describes how to use nanometer scale fluorescence particles as a label material for fluorescence lateral flow device application. The utilization of the nanoparticles instantly increases the fluorescence intensity by thousands to millions of times. The resulting signal enhancement not only significantly increase sensitivity for analyte detection, but also makes it possible to use low power light sources for illumination and low cost detectors for fluorescence detection.Type: ApplicationFiled: October 12, 2007Publication date: March 5, 2009Inventor: Winston Z. Ho
-
Publication number: 20090042237Abstract: This invention describes a point-of-care or home use device for measuring the ratio of glycated albumin to total albumin in saliva and other body fluids. Diabetics and prediabetics may have elevated levels of glucose in their blood that can react with plasma albumin to form glycated albumin. The amount of glycated albumin formed is directly correlated with the level of plasma glucose that the albumin has been exposed to over a period of time. Saliva albumin is derived from plasma albumin and therefore contains glycated and non-glycated albumin fractions that can be measured. The ratio of glycated albumin to total albumin in saliva will provide an indication of the average amount of protein glycation that occurred over the preceding 2-3 week period. The test is performed using a disposable strip or cassette that contains the testing reagents and the results are measured in a measuring instrument that automatically reads, calculates and displays the final result.Type: ApplicationFiled: August 4, 2008Publication date: February 12, 2009Inventor: Henry John Smith
-
Publication number: 20090029452Abstract: Disclosed is a testing device and methods for the identification of an analyte of interest in a sample. In a preferred embodiment, the testing device includes a front panel having at least one sample application aperture; a rear panel having at least one solvent application aperture; a sample collection matrix disposed between the rear panel and the front panel, the sample collection matrix being in communication with the sample and solvent application apertures of the front and rear panels; and at least one insertable test strip containing a reagent enabling detection of the analyte of interest.Type: ApplicationFiled: May 12, 2008Publication date: January 29, 2009Inventor: Howard Milne Chandler
-
Publication number: 20080286857Abstract: The invention provides a multi-functional polymer-entrapped-cell-bead airlift bioreactor for odor or gaseous emission treatment. Especially, it refers to a reactor that mainly treats a low-and-medium gas flow rate and concentration of volatile organic emission or odorous substances. Particularly, it utilizes synthetic material (PAA beads) and microbial entrapment technology as the microbial source and startup mechanism for gaseous emission and odor treatment. Besides, plastic decomposing Thiosphaera pantotropha can be added under certain condition to be triggered to breakdown the synthetic material (PAA beads) to prevent wastes. This will achieve benefits in low cost, high efficiency and zero secondary pollution.Type: ApplicationFiled: April 21, 2008Publication date: November 20, 2008Inventors: Sz-Chwun John Hwang, Hsin-Hua Chen, Kuo Shu Huang, Jyuhr Yih Lyuu, Yun-Huin Lin, Cheng-Ting Hou
-
Patent number: 7449329Abstract: A blood crossmatching apparatus, kit and methods for testing the compatibility of mammals for blood transfusion. Particulate layers in the apparatus allow nonagglutinated red blood cells to permeate through, while agglutinated red blood cells cannot. The apparatus also has a density solution layered above particulate layers. The density solution separates white blood cells from red blood cells in the whole blood when centrifuged, without lysing the red blood cells. Thus, the apparatus can be used to test whole blood.Type: GrantFiled: March 31, 2006Date of Patent: November 11, 2008Inventor: Anne S. Hale
-
Patent number: 7396674Abstract: Reaction vessel 1 for assaying of a subject substrate molecule comprises a translucent narrow tube 2 which has a liquid feed port 4 at one end, and which is intended to be packed with microparticles 5 as solid phase support on which a reagent molecule is bound thereto, in which said reagent is capable of binding to, adsorbing, or showing affinity with the subject substrate molecule, and a effluent collecting tube 3 in which a liquid absorbing member 13 is provided inside for absorbing the liquid poured into the narrow tube, and which is connected to the narrow tube 2 at its downstream via a communicating passage 11, and a current-controlling mechanism for controlling liquid current in the narrow tube so as to hold the liquid in the narrow tube 2 during a predetermined time.Type: GrantFiled: March 22, 2007Date of Patent: July 8, 2008Assignee: Itoham Foods, Inc.Inventors: Junji Miyakawa, Asami Matsumoto, Shusaku Oka
-
Patent number: 7368282Abstract: A process and device are disclosed to determine the activity of enzymes in liquids in a largely automatic manner. The device for carrying out this process has a column (1) with a chromatographic carrier for treating a measurement sample. The carrier is mixed with a substance capable of binding to an enzyme inhibitor present in the measurement sample and that corresponds to at least one enzyme. A measurement sample supply (2) is associated to one end of the column (1). A valve/pump arrangement (7, 11, 14, 15) for filling at least one test tube (5) with a carrier and at least part of the measurement sample is connected downstream of the column (1), in the flow direction of the measurement sample. The carrier is dissociated into cleavage products by the action of the enzyme. The rise in concentration per unit of time of at least one of the cleavage products of the carrier is sensed during an incubation time.Type: GrantFiled: December 19, 2002Date of Patent: May 6, 2008Inventors: Johannas Schumacher, Bernd Werle
-
Patent number: 7364899Abstract: The present invention discloses a device for monitoring haptotaxis including a housing defining a chamber. The chamber comprises: a first well region including at least one first well, the first well configured to receive a test agent therein and further including biomolecules immobilized therein; a second well region including at least one second well, the second well region configured to receive a sample comprising cells therein and further being horizontally offset with respect to the first well region in a test orientation of the device; and a channel region including at a least one channel connecting the first well region and the second well region with one another, the channel region further including biomolecules immobilized therein.Type: GrantFiled: March 15, 2002Date of Patent: April 29, 2008Assignee: Surface Logix Inc.Inventors: Gregory L. Kirk, Matthew Brown, Emanuele Ostuni, Enoch Kim, Bernardo D. Aumond, Olivier Schueller, Paul Sweetnam, Brian Benoit
-
Patent number: 7326561Abstract: A system for performing hybridization assays comprises a cartridge for housing a flow through device, where the cartridge includes a test fluid chamber for facilitating a substantially uniform flow of a test fluid mixture through the flow through device, and a fluidics station to deliver the test fluid mixture to the cartridge. The cartridge has a chip holder that holds the flow-through device, which has an array of microchannel passages. The chip holder has a support for placement of the flow though device, the test fluid chamber for directing a substantially uniform flow of a test fluid mixture through the array of microchannel passages of the flow through device, and a first port that receives the test fluid mixture. The cartridge has a sealing system for preventing the leakage of the test fluid around the flow through device. The test fluid chamber is defined in part by a spade-like surface having an inlet for the test fluid mixture.Type: GrantFiled: December 20, 2000Date of Patent: February 5, 2008Inventors: Jack Goodman, Matthew Torres, Hongjun Yang, David G. Mateer, Ian Stuart Richard Smith
-
Patent number: 7217562Abstract: The present invention relates to a device for interfacing nanofluidic and microfluidic components suitable for use in performing high throughput macromolecular analysis. Diffraction gradient lithography (DGL) is used to form a gradient interface between a microfluidic area and a nanofluidic area. The gradient interface area reduces the local entropic barrier to nanochannels formed in the nanofluidic area. In one embodiment, the gradient interface area is formed of lateral spatial gradient structures for narrowing the cross section of a value from the micron to the nanometer length scale. In another embodiment, the gradient interface area is formed of a vertical sloped gradient structure. Additionally, the gradient structure can provide both a lateral and vertical gradient.Type: GrantFiled: April 16, 2003Date of Patent: May 15, 2007Assignee: Princeton UniversityInventors: Han Cao, Jonas O. Tegenfeldt, Stephen Chou, Robert H. Austin
-
Patent number: 7192784Abstract: A substantial amount of a marker reagent associated with a measurement is measured in a marker reagent measurement area, and the substantial amount of the marker reagent is reflected by a result obtained in a reaction result measurement area where a reaction with a measurement target in an inspection target solution is measured. Thereby, an influence of external environmental factors, factors in a property of the inspection target solution, an erroneous operation in a measurement operation or the like is eliminated, whereby a chromatography measuring method employing a biosensor with higher accuracy and higher reliability can be provided.Type: GrantFiled: May 8, 2001Date of Patent: March 20, 2007Assignee: Matsushita Electric Industrial Co., Ltd.Inventors: Masataka Nadaoka, Mie Takahashi, Hirotaka Tanaka